- Poster presentation
- Open Access
Association of miR-27a, miR-181a and miR-570 genetic variants with gallbladder cancer susceptibility on North indian population
© Gupta et al; licensee BioMed Central Ltd. 2014
- Published: 21 January 2014
- Cancer Susceptibility
- Gallbladder Cancer
- Bioinformatics Tool
- TaqMan Probe
- Gallbladder Carcinoma
MicroRNAs are small endogenously expressed short non-coding RNAs. They appear to be critical regulators of tumor biology as their aberrant expression is well characterized in cancer progression. The role of microRNA is not fully understood in gallbladder carcinoma, so in present study we investigated the role of miR-27a, miR-181a and miR-570 genetic variants with gallbladder cancer (GBC) susceptibility.
In this case-control study, we evaluated the role of miR-27a, miR-181a and miR-570 genetic polymorphisms with GBC susceptibility in North Indian population. The present study included 515 GBC patients and 200 healthy controls from North India. Genotypes were determined by TaqMan probes. Statistical analysis was done by SPSS ver. 16. In silico analysis was performed using Bioinformatics tools (F-SNP, FAST-SNP).
Logistic regression analysis showed no significant association of miR-27a, miR-181a and miR-570 genetic polymorphism with GBC susceptibility (P> 0.05). On stratifying our data on the basis of gall stone status, the [AG+GG] genotypes of miRNA rs895819 (A>G) were significantly associated with increased risk of GBC in patients without stone (p=0.003 OR=1.83 [(95%CI) 1.23-2.72]. The genetic risk by miR-27a, rs895819 (A>G) was also modulated by tobacco consumption as the heterozygotes (AG) were at higher risk p=0.005 OR=1.94 [(95%CI) 1.22-3.08]. However, there was no association of miR-181a and miR-570 polymorphisms with disease risk in subgroup analysis. In-silico analysis showed change in transcriptional regulation of miR-27a and miR-570 variations.
We found significant association of miRNA rs895819 A>G with gallbladder cancer risk through gallstone independent pathway and tobacco usage.
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.